Shanghai InnoStar Bio-tech Co (SHSE:688710) ROCE % : 7.79% (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Shanghai InnoStar Bio-tech Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Shanghai InnoStar Bio-tech Co's annualized ROCE % for the quarter that ended in Sep. 2024 was 7.79%.

Shanghai InnoStar Bio-tech Co ROCE % Historical Data

The historical data trend for Shanghai InnoStar Bio-tech Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai InnoStar Bio-tech Co ROCE % Chart

Shanghai InnoStar Bio-tech Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

16.83

14.70

14.44

11.27

12.39

Shanghai InnoStar Bio-tech Co Quarterly Data
	Dec19	Dec20	Dec21	Jun22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial							-	3.25	62.51	-37.45	7.79

Shanghai InnoStar Bio-tech Co ROCE % Calculation

Shanghai InnoStar Bio-tech Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	223.697	/	( ( (2618.267 - 901.705)	+	(2775.441 - 881.305) )	/ 2 )
	=	223.697	/	( (1716.562	+	1894.136)	/ 2 )
	=	223.697	/	1805.349
	=	12.39 %

Shanghai InnoStar Bio-tech Co's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	179.568	/	( ( (2644.962 - 664.621)	+	(3263.196 - 631.527) )	/ 2 )
	=	179.568	/	( ( 1980.341	+	2631.669 )	/ 2 )
	=	179.568	/	2306.005
	=	7.79 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Shanghai InnoStar Bio-tech Co (SHSE:688710) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Shanghai InnoStar Bio-tech Co ROCE % Related Terms

Thank you for viewing the detailed overview of Shanghai InnoStar Bio-tech Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai InnoStar Bio-tech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai InnoStar Bio-tech Co Ltd (SHSE:688710) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 199 Guo Shoujing Road, Room 106, Pilot Free Trade Zone, Shanghai, CHN, 201203

Website

https://www.innostar.cn

Shanghai InnoStar Bio-tech Co Ltd is a comprehensive research and development services (CRO) enterprise that specializes in providing biomedical non-clinical research services.

Shanghai InnoStar Bio-tech Co Headlines

No Headlines